Celgene COO resigns suddenly

Apr 03, 2018

Celgene have announced that Chief Operating Officer Scott Smith is leaving the company, effective immediately. The biopharma company did not cite a reason for his departure but the announcement comes weeks after the FDA turned down Celgene’s high-profile MS drug.

Chief executive officer Mark Alles will assume Smith’s responsibilities. Alles is now directly responsible for all major parts of its business.

Smith joined Celgene in 2008 and served as its president and chief operating officer since April 2017.

Read the Reuters report

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments